These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6719452)

  • 1. Formation of a vasopressor substance in the incubated serum of patients with various hypertensive diseases.
    Maebashi M; Yoshinaga K
    Tohoku J Exp Med; 1984 Feb; 142(2):173-82. PubMed ID: 6719452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pressor substance in the cerebrospinal fluid of normotensive and hypertensive patients.
    Finkielman S; Fischer-Ferraro C; Diaz A; Goldstein DJ; Nahmod VE
    Proc Natl Acad Sci U S A; 1972 Nov; 69(11):3341-4. PubMed ID: 4343964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new pressor agent of renal origin: its differentiation from renin and angiotensin.
    Grollman A; Krishnamurty VS
    Am J Physiol; 1971 Nov; 221(5):1499-506. PubMed ID: 4330896
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence that the renal pressor substance of Grollman is related to angiotensin I.
    Schweikert JR; Carey RM; Liddle GW; Island DP
    Circ Res; 1972 Sep; 31(9):Suppl 2:132-42. PubMed ID: 4341472
    [No Abstract]   [Full Text] [Related]  

  • 5. WB1106, a novel nitric oxide-releasing derivative of telmisartan, inhibits hypertension and improves glucose metabolism in rats.
    Li YQ; Ji H; Zhang YH; Shi WB; Meng ZK; Chen XY; Du GT; Tian J
    Eur J Pharmacol; 2007 Dec; 577(1-3):100-8. PubMed ID: 17822696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A possible etiology of contractility impairment of vascular smooth muscle from spontaneously hypertensive rats.
    Shibata S; Kurahashi K; Kuchii M
    J Pharmacol Exp Ther; 1973 May; 185(2):406-17. PubMed ID: 4350041
    [No Abstract]   [Full Text] [Related]  

  • 7. Humoral vasopressor agents in primary hypertension.
    Zidek W; Vetter H
    Clin Physiol Biochem; 1987; 5(1):38-48. PubMed ID: 3034471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel platelet-derived renal vasoconstrictor agent in normotensives and essential hypertensives.
    Agha A; Schlüter H; König S; Biel K; Tepel M; Zidek W
    J Vasc Res; 1992; 29(3):281-9. PubMed ID: 1324015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats.
    Stanke-Labesque F; Devillier P; Veitl S; Caron F; Cracowski JL; Bessard G
    Cardiovasc Res; 2001 Jan; 49(1):152-60. PubMed ID: 11121807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of hypothalamic angiotensin receptors produces pressor responses via cholinergic inputs to the rostral ventrolateral medulla in normotensive and hypertensive rats.
    Kubo T; Hagiwara Y; Endo S; Fukumori R
    Brain Res; 2002 Oct; 953(1-2):232-45. PubMed ID: 12384257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in vascular sensitivity to vasoactive agents after discontinuation of propranolol in SHR.
    Kubota T; Yamada T
    Hypertension; 1984; 6(2 Pt 1):249-54. PubMed ID: 6327518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented endothelium-dependent contraction to angiotensin II in the SHR aorta: role of an inducible cyclooxygenase metabolite.
    Zerrouk A; Auguet M; Chabrier PE
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):525-33. PubMed ID: 9554800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose angiotensin II enhances pressor responses without causing sustained hypertension.
    Pelaez LI; Manriquez MC; Nath KA; Romero JC; Juncos LA
    Hypertension; 2003 Oct; 42(4):798-801. PubMed ID: 12874085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro effects of cicletanine in spontaneously hypertensive rats.
    Auguet M; Guillon JM; Delaflotte S; Le Hegarat M; Pirotzky E; Clostre F; Braquet P
    Drugs Exp Clin Res; 1988; 14(2-3):89-95. PubMed ID: 3416727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic effects of angiotensin (1-7) and its interactions with angiotensin II in rat aorta.
    Haulica I; Bild W; Mihaila CN; Ionita T; Boisteanu CP; Neagu B
    J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):124-8. PubMed ID: 12806596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
    Iyer SN; Ferrario CM; Chappell MC
    Hypertension; 1998 Jan; 31(1 Pt 2):356-61. PubMed ID: 9453328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction by (-)-cicletanine of the vascular reactivity to angiotensin II in rats.
    Alvarez-Guerra M; Alda O; Morin E; Allard M; Garay RP
    J Cardiovasc Pharmacol; 1996 Oct; 28(4):564-70. PubMed ID: 8891883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered muscle metabolism associated with vasoconstriction in spontaneously hypertensive rats.
    Ye JM; Colquhoun EQ
    Am J Physiol; 1998 Dec; 275(6):E1007-15. PubMed ID: 9843743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular effects of 15-F2t-isoprostane in spontaneously hypertensive rats.
    Marlière S; Cracowski JL; Hakim A; Stanke-Labesque F; Hoffmann P; Bessard G
    Can J Physiol Pharmacol; 2005 Jun; 83(6):453-8. PubMed ID: 16049544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.